(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ORICIRO

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

ORICIRO

ST13

US500000079274176

Classe

1, 5, 9, 40, 42

Pedido

79274176

Registro

6197550

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

27

Atualização mais recente

18/11/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 5, 9, 40, 42

Data de depósito

23/07/2019

Data de registro

17/11/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

17/11/2020

Última transação

18/11/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

03

Localização do titular

JP

Examinador

STEDMAN, CORI

Unidade examinadora

N50

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of a design of a waved circle with five convex parts and five concave parts in blue-grey, interwoven with a waved semicircle with three convex parts and three concave parts in blue to the left of the word "ORICIRO" in black. The color white represents background, outlining, shading, and/or transparent area is not part of the mark.

Titulares e representantes

Titulares

OriCiro Genomics, Inc.

Representantes

Sandra Epp Ryan Hamre, Schumann, Mueller & Larson, P.C.

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical reagents for genetic researchother than for medical or veterinary purposes; chemical reagentsother than for medical or veterinary purposes; reagents for scientific and research usefor DNA amplification; reagents for genetic research purposesother than for medical or veterinary purposes; reagents for research purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals; test paperchemical; reagent paperother than for medical or veterinary purposes

Classe 5

Chemical reagents for medical purposes; diagnostic reagents for medical purposes; reagents for use in medical genetic testing; reagentsfor medical purposes; diagnostic preparations for medical purposes; pharmaceutical preparationsfor the treatment of diseases caused by genetic disorder; reagent paper for medical purposes

Classe 9

Genetic specimen samplersother than for medical usetesting sample collection equipment in the nature of wipes and swabs for use in diagnostic testingnot for medical purposes; DNA chips; DNA chip making apparatus being a DNA microarray apparatus; DNA synthesizing apparatusDNA microarray; DNA analyzing apparatuslaboratory research instruments for DNA analysis; scientific apparatus and instruments and laboratory apparatus for research purposespolymerase chain reaction thermocyclers used to amplify DNAfor analytical and research purposes; DNA fragmentation apparatuslaboratory apparatus to separate or for breaking DNA strands into pieces; gene testing equipment for research purposeselectrical equipment for the genetic modification of cells for research purposes; analytical apparatuslaboratory apparatus for extracting DNA for use in laboratory; laboratory kits for use with reagents for DNA amplification comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory kits for use with reagents for genetic research comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory apparatus and instruments in the form of kits comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; measuring or testing machines and instrumentsscientific apparatus and instruments for measuring relative DNARNA and protein

Classe 40

Custom treatment of materials in the nature of syntheses of DNA; custom treatment of materials in the nature of syntheses of RNA; custom treatment of materials in the nature of syntheses of nucleic acids; custom treatment of materials in the nature of amplification of DNA; custom manufacture of chemicals; processing of chemical reagents; processing of medicinal materialsmedicinal plants; custom manufactureextractionpurification and syntheses of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of biopharmaceutical materials by means of DNA engineering; providing material treatment information

Classe 42

Testinginspectionresearch or development services in the fields of genesresearch in the fields of geneticsgene therapyDNA and chemical and biological production methods; consultancy and information services relating to testinginspectionresearch or development services in the fields of genesscientific research consulting in the fields of geneticsgene therapyDNA and chemical and biological production methods; scientific research in the fields of genetics and genetic engineering; testinginspectionresearch or development services in the fields of chemistryscientific research and development in the fields of chemistry; consultancy and information services relating to testinginspectionresearch or development services in the fields of chemistrychemistry consultation; testinginspectionresearch or development services in the fields of pharmaceuticalstestinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy including DNA and RNA-based therapy and vaccines; consultancy and information services relating to testinginspectionresearch or development services in the fields of pharmaceuticalsscientific research consulting in the fields of pharmaceuticals; testinginspection or research on agriculturelivestock breeding or fisheries; testing or research on prevention of pollution; scientific laboratory services

Publicações

Histórico de despachos e eventos da marca no USPTO.

27 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

17/11/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

20/01/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

20/01/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

20/01/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

20/01/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

21/03/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

26/02/2021

FIMP

FINAL DISPOSITION PROCESSED

26/02/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

17/02/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/12/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

17/11/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/09/2020

PUBO

PUBLISHED FOR OPPOSITION

01/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/08/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

24/07/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/07/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/07/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/07/2020

RFNT

REFUSAL PROCESSED BY IB

08/02/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

23/01/2020

RFRR

REFUSAL PROCESSED BY MPU

23/01/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

24/12/2019

MAFR

APPLICATION FILING RECEIPT MAILED

24/12/2019

CNRT

NON-FINAL ACTION WRITTEN

23/12/2019

DOCK

ASSIGNED TO EXAMINER

20/12/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/12/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

19/12/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ORICIRO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.